06.11.26 -- Why Contamination Control By Design Should Matter To Your CDMO

Explore how data‑driven collaboration and animal‑origin‑free media strategies can reduce variability, improve cell culture performance, and support consistent, cost‑effective bioprocessing at scale.

Balance specificity and potency in genome editing. This webinar covers AI-driven optimization and tailored editor designs built to elevate clinical-stage genetic medicine workflows.

Bispecific antibodies combine two antigen-binding sites for better efficacy. Learn the structural strategies, MOA-based evaluations, and screening methods that optimize performance.

Review the primary challenges of moving stem cell programs to GMP. These insights highlight process design and variability control to ensure reliable clinical manufacturing.

Examine critical factors in cell line development. See how recent technological breakthroughs improve efficiency, boost productivity, and shape the future of bioprocessing.

Missteps in tech transfer risk high costs and poor quality. Achieve success by aligning your internal sponsor strategy with the strengths of an experienced, collaborative partner.

Discover how scalable, cost-effective, and high-quality lentiviral vector manufacturing can accelerate both ex vivo and emerging in vivo CAR-T therapies.

Advances in genome engineering and immune evasion are enabling scalable, durable allogeneic cell therapies, overcoming rejection challenges and expanding potential treatments across diverse diseases.